ABBV vs. JNJ: One of These Dividend Aristocrats Will Crush the Other Over the Next Decade - 24/7 Wall St.
ABBV vs. JNJ: One of These Dividend Aristocrats Will Crush the Other Over the Next Decade 24/7 Wall St.
Covered in this story
What has happened since
- AbbVie is up 1.1% since this was published, 3 days ago.
- Johnson & Johnson is up 0.3% since this was published, 3 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ABBV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on AbbVie →Dalsna Finance is currently tracking 52 stories mentioning AbbVie, the earliest published 19 Mar 2026.
Summary aggregated from Google News's public RSS feed. The full reporting belongs to Google News — please read it on their site.